Introduction {#s1}
============

Overweight and obesity affect more than 1.9 billion adults globally.^[@R1]^ Obesity has become a primary health issue in several Asia countries including in Malaysia. Nearly 50% of the Malaysian adults are reported to be overweight and about 17.7% of them are obese as were unveiled in the National Health and Morbidity Survey in 2015.^[@R2]^ Obesity is commonly associated with several life-threatening diseases including stroke, cardiovascular disease,type 2 diabetes and cancers.^[@R3]-[@R7]^ The etiology of overweight and obesity that subsequently affect the pathophysiological characteristics is not fully understood, but it seems to involve both genetic and environmental elements in this pandemic disease.

A genome-wide linkage scan in Pima Indians revealed that chromosome 17q25 has the strongest evidence for linkage with the percentage of body fat.^[@R8]^ The fatty acid synthase (*FASN*) gene is located in this region and it encodes a core enzyme that is essential for *de novo* lipogenesis pathway and cellular substrate energy metabolism including the synthesis of long-chain fatty acids from acetyl-CoA, malonyl-CoA and NADPH ([Fig. 1](#F1){ref-type="fig"}).^[@R9]^ Previous studies in mice model suggested that inhibition of the *FASN* gene expression had led to reducing food intake, rapid weight and fat loss, as well as resolution of fatty liver in diet-induced obese mice.^[@R10]-[@R12]^ Taken together, *FASN* gene is evidently and actively involving in the energy homeostasis process, making it an interesting gene to be studied for association with the risk of overweight and obesity in human populations.

![](bi-8-159-g001){#F1}

Sequencing of *FASN* gene in Pima Indians and Germans has successfully identified several single nucleotide polymorphisms (SNPs) within the gene.^[@R13],[@R14]^ Some of these SNPs, including the rs4246445, rs2229425, rs2228305, and rs2229422 have been significantly associated with the risk of obesity in Germans,^[@R14]^ but yet to be investigated in the Malaysian population. Therefore, we report here the association of these 4 SNPs with the risk of overweight and obesity in the Malaysian population, including other factors such as gender, smoking status, alcohol consumption and fast-food intake. We are also interested to study the effect of linkage disequilibrium (LD) and haplotypes of these SNPs towards the risk of overweight and obesity in the population.

Materials and Methods {#s2}
=====================

Subjects {#s2-1}
--------

Five milliliters of peripheral blood was collected from 1030 age-matched volunteers with written consent from the year 2014 to 2016. Information such as age, gender, height, weight, blood pressure, heart rate and lifestyles were obtained from all recruited subjects. The subjects were further divided into 3 groups based on their body mass index (BMI), including normal group with BMI \<25.0 kg/m^2^(*N* = 694, mean age ± S.D. = 23.41 ± 9.81), overweight group with BMI = 25.0--29.9 kg/m^2^(*N* = 223, mean age ± S.D. = 23.34 ± 9.78), and obese group with BMI ≥30.0 kg/m^2^(*N* = 113, mean age ± S.D. = 23.45 ± 9.88). Blood biochemistry and lipid profile for each group were analyzed.

DNA isolation and integrity measurement {#s2-2}
---------------------------------------

Genomic DNA was isolated from peripheral blood of all subjects using alkaline phenol-chloroform approach. Standard Sensitivity Genomic DNA Analysis Kit was purchased to measure the quality of the extracted DNA using Fragment Analyzer^TM^ (Advanced Analytical Technologies Inc., IA, USA). A genomic quality number (GQN) which represented the integrity of DNA for each sample was obtained and only high intact DNA with GQN \>7.0 was selected for subsequence analysis.

Genotyping of FASN polymorphisms {#s2-3}
--------------------------------

TaqMan^®^ genotyping assays (ABI, USA) for *FASN* rs4246445, rs2229425, rs2228305, and rs2229422 SNPs (Table S1) were purchased and genotyped using StepOnePlus^TM^ Real-time PCR System (ABI, USA). Briefly, a PCR mixture containing 100 ng of genomic DNA, 5 µL of 2X TaqMan^®^ GTXpress^TM^ Master Mix (ABI, USA) and 0.5 µL of 20X TaqMan^®^ genotyping assay was prepared. The mixture was topped-up with sdH~2~O to a final volume of 10 µL. The PCR condition was set at: an enzyme activation step at 95°C for 20 seconds followed by 40 cycles of 95°C for 3 seconds and 60ºC for 30 seconds.

Statistical analyses {#s2-4}
--------------------

Independent t-test was applied to compare the mean differences of health characteristics between overweight and/or obese groups to the normal group using SPSS software version 17.0 (IBM Corporation, USA). Hardy-Weinberg equilibrium (HWE) for all 4 SNPs was determined using the Online Encyclopedia for Genetic Epidemiology software.^[@R15]^ Odd ratio (OR) with 95% CI was calculated in overall and in the sub-groups (e.g. gender, smoking status, alcohol consumption, and fast-food intake) using online MEDCALC^®^ software (<https://www.medcalc.org/calc/odds_ratio.php>). LD and haplotype analyses were performed using SHEsis online software.^[@R16]^ Independent chi-square test in the SPSS software version 17.0 (IBM Corporation, USA) was utilized to compare the distribution of the allele frequencies between this study and other populations. All *P* values were two-tail and considered statistically significant when *P* \< 0.05.

Results {#s3}
=======

Demographic data of the normal, overweight, and obese subjects ([Table 1](#T1){ref-type="table"}) showed that overweight subjects had significantly higher BMI values when compared to normal subjects. Several parameters such as weight, BMI, systolic blood pressure, hemoglobin and white blood cell counts were significantly different between the normal and obese groups. When overweight and obese subjects were combined and analyzed together, their BMI and hemoglobin level were significantly higher than the normal subjects.

###### Demographic data of the normal, overweight, and obese groups

  ----------------------- ---------------- ---------------- ------------------ -------------------
  **Demography**          **NR (n=694)**   **OW (n=223)**   **OB (n=113)**     **OW+OB (n=336)**
  Gender (Male/Female)    433/261          134/89           53/60              187/149
  Age (y)                 23.41±9.81       23.34±9.78       23.45±9.88         26.76±12.63
  Height (cm)             170.25±10.97     168.25±11.62     159.50±12.71       163.88±12.21
  Weight (kg)             62.25±6.80       74.00±10.68      90.50±19.60^\*^    82.25±17.07
  BMI (kg/m^2^)           21.45±1.29       26.05±0.73^\*^   35.30±3.73^\*^     30.67±5.54^\*^
  Systolic (mm Hg)        117.00±7.75      125.50±12.45     128.50±4.12^\*^    127.00±8.73
  Diastolic (mm Hg)       75.75±7.80       78.25±5.12       84.75±3.59         81.50±5.37
  Pulse (per min)         72.00±13.44      80.75±9.57       76.75±5.68         78.75±7.59
  Haemoglobin (g/L)       132.27±20.27     144.42±17.95     150.71±15.97^\*^   146.74±17.08^\*^
  RBC (x10^12^/L)         4.88±0.60        4.96±0.75        5.37±0.55          5.11±0.70
  WBC (x10^9^/L)          6.49±1.37        6.89±1.43        7.93±2.11^\*^      7.27±1.73
  Platelets (x10^9^/L)    280.58±65.45     275.58±62.24     271.00±50.58       273.89±58.13
  Glucose (mmol/L)        5.30±0.56        5.17±0.46        5.89±2.85          5.43±1.72
  Cholesterol (mmol/L)    4.48±0.44        4.83±0.87        5.73±2.04          5.28±1.53
  HDL (mmol/L)            1.54±0.45        1.55±0.15        1.21±0.35          1.38±0.31
  LDL (mmol/L)            2.52±0.71        2.98±0.99        3.39±0.60          3.18±1.03
  Triglyceride (mmol/L)   0.90±0.31        0.65±0.15        2.44±1.94          1.55±1.59
  ----------------------- ---------------- ---------------- ------------------ -------------------

NR, normal (BMI \< 25.0 kg/m^2^); OW, overweight (BMI = 25.0-29.9 kg/m^2^); OB, obese (BMI ≥ 30.0 kg/m^2^); BMI, body mass index; RBC, red blood count; WBC, white blood count; HDL, high density lipid; LDL, low density lipid.

^\*^Statistically significant when compared to normal (*P* \< 0.05).

The *FASN* rs4246445 and rs2229425 SNPs were within the HWE (χ^2^ \< 3.84), whereas *FASN* rs2228305 and rs2229422 SNPs deviated from the HWE (χ^2^\> 3.84) in the population. The highest minor allele frequency (MAF) was observed in the rs4246445 (MAF = 0.363) followed by rs2229422 (MAF = 0.186), rs2228305 (MAF = 0.022) and rs2229425 (MAF = 0.003). Risk association analysis revealed no significant association of all these SNPs with overweight, obesity, and overweight + obesity when compared to normal subjects in this study including in the sub-groups (i.e. gender, smoking status, alcohol consumption, and fast-food intake) analyses (Tables S2-S5).

LD and haplotype analyses of all SNPs with the overweight + obese (BMI ≥ 25.0; N = 336) as cases, and normal group (BMI \< 25.0; N = 694) as controls showed that the rs4246445 and rs2229425 SNPs, as well as the rs2229425 and rs2228305 SNPs were in strong LD with D' values of 0.986 and 1.000, respectively. However, both LD were with extremely low r^2^ values ([Fig. 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). We have identified five common haplotypes (defined by the composition of alleles at each SNP in the following order: rs4246445-rs2229425-rs2228305-rs2229422) where haplotypes TCGT, TCGC and CCAT exhibited slightly higher frequencies while haplotypes CCGT and CCGC were in lower frequencies in cases than in controls, but none of these haplotypes was statistically significant (*P* \> 0.05) ([Table 3](#T3){ref-type="table"}).
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###### Linkage disequlibrium (LD) analysis of *FASN* polymorphisms in this study

  ----------- --------------- --------------- --------------- ---------------
  **SNP**     **rs4246445**   **rs2229425**   **rs2228305**   **rs2229422**
  rs4246445                   0.986           0.789           0.590
  rs2229425   0.005                           1.000           0.731
  rs2228305   0.025           0.000                           0.575
  rs2229422   0.139           0.007           0.002           
  ----------- --------------- --------------- --------------- ---------------

Values in upper diagonal and lower diagonal represented the D' and r^2^for the SNP combinations, respectively

###### Haplotype analysis of *FASN* polymorphisms in this study

  -------------------- ------------------------------ ------------------------------- ------------------ ---------
  **Haplotype** ^\*^   **OW+OB (Frequency)** ^\*\*^   **Normal (Frequency)** ^\*\*^   **OR (95% CI)**    ***P***
  TCGT                 0.598                          0.583                           1.06 (0.88-1.28)   0.527
  TCGC                 0.050                          0.044                           1.14 (0.74-1.75)   0.553
  CCGT                 0.199                          0.208                           0.95 (0.75-1.19)   0.655
  CCGC                 0.127                          0.140                           0.89 (0.68-1.17)   0.410
  CCAT                 0.020                          0.019                           1.07 (0.55-2.06)   0.843
  -------------------- ------------------------------ ------------------------------- ------------------ ---------

OW, overweight; OB, obese.

^\*^As listed in [Table 3](#T3){ref-type="table"} based on the physical marker order: rs4246445, rs2229425, rs2228305 and rs2229422.

^\*\*^All haplotype frequencies less than 0.010 were ignored in the analysis.

Discussion {#s4}
==========

Blood biochemistry and compositions have been intensively studied in correlation with the overweight and obesity pandemics, and several indicators were successfully identified in peripheral blood of overweight and obese when compared to individuals with normal BMI.^[@R17],[@R18]^ To further extend the study on this perspective, we have performed full blood and lipid profiling of the collected blood samples, and our results showed significantly higher hemoglobin level in the obese and overweight+obese individuals. We have established the positive correlation between BMI and hemoglobin count, which is similar to previously reported studies.^[@R17],[@R18]^ Interestingly, our study revealed that WBC was significantly higher in the obese than in normal subjects. Obesity is often associated with chronic, systemic and low-grade inflammation, and recent reviews have summarized the crucial role of immune mechanisms in obesity-induced inflammation,^[@R19],[@R20]^ explaining the obvious elevated WBC in the obese subjects in this study. Furthermore, obese individuals tend to have a higher risk of stroke or cardiovascular disease as the adipokines released by the obese adipose tissues may induce oxidative stress as well as microvascular and endothelial dysfunctions that considered as the essential steps of atherogenesis.^[@R3],[@R4],[@R19],[@R21]^

The T allele was reported as the minor allele for the rs4246445 SNP and the distributions of this allele were significantly different in the South Asian (MAF = 44.0%, *P* = 0.005), African (MAF = 19.0%, *P *≤ 0.001), European (MAF = 25.0%, *P* \< 0.001) and Ad Mixed American (MAF = 23.0%, *P* \< 0.001) populations when compared to the Malaysian in this study ([Fig. 3](#F3){ref-type="fig"}). Interestingly, this allele is more dominant in our population with the allele frequency of 63.7%, which is comparable to the East Asian population (MAF = 58.0%, *P* = 0.384). Therefore this allele was selected as the reference for subsequent risk association analysis. Overall, no significant association was observed for the rs4246445 SNP with the risk of overweight and obesity in this study. However, the presence of T allele in this SNP is seemed to have a higher risk for overweight and obesity in our study population but moderately protective against obesity in Germans by 0.83-fold after adjustment with age, gender, and type 2 diabetes though not significant.^[@R14]^ The distribution of the T allele frequency of this SNP is significantly different between our population and Germans ([Fig. 4](#F4){ref-type="fig"}). These findings indicate that the risk association of this SNP towards obesity prevalence is population-dependent.
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The MAF distribution of the rs2229425 SNP in our population is similar to the East Asian (MAF = 0.0%) and African (MAF = 1.0%, *P* = 0.316) populations but significantly different to other populations including South Asian (MAF = 4.0%, *P* = 0.043), European (MAF = 13.0%, *P* \< 0.001) and Ad Mixed American (MAF = 8.0%, *P* = 0.004) ([Fig. 5](#F5){ref-type="fig"}). For the rs2229422 SNP, the distribution of the allele frequencies is similar with the East Asian (MAF = 29.0%, *P* = 0.098), South Asian (MAF = 18.0%, *P* = 0.856), African (MAF = 20.0%, *P* = 0.858), European (MAF = 31.0%, *P* = 0.050) and Ad Mixed American (MAF = 20.0%, *P* = 0.858) populations ([Fig. 6](#F6){ref-type="fig"}). The variant allele in the rs2229425 and rs2229422 SNPs has been reported as a significant risk factor for obesity in Germans with OR (95% CI) of 1.72 (1.35-2.18) and 1.85 (1.35-2.56), respectively, after adjusted for the age, sex, and type 2 diabetes.^[@R14]^ However, the presence of the variant allele in these two SNPs does not associate with the risk of overweight and obesity in this study.
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Distribution of allele frequencies of the rs2228035 SNP in our population is significantly different with the South Asian population (MAF = 10.0%, *P* = 0.017) but statistically similar to other populations including East Asian (MAF = 1.0%, *P* = 0.561), African (MAF = 7.0%, *P* = 0.088), European (MAF = 3.0%, *P* = 0.651) and Ad Mixed American (MAF = 5.0%, *P* = 0.248) ([Fig. 7](#F7){ref-type="fig"}). Notably, the appearance of the variant A allele in the rs2228305 SNP has been reported to be protective against obesity in different populations, especially in male subjects.^[@R13],[@R14],[@R22],[@R23]^ The distribution of allele frequency of this SNP in Germans was similar to our population (*P* = 0.407) and our study also revealed that the variant allele of this SNP is more likely to defend against obesity in male subjects though no significant association was observed, indicating that the association of the rs2228305 SNP with the risk of overweight and obesity could be gender-specific.
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Sequencing of the *FASN* gene in Pima Indians and Germans successfully discovered 13 and 35 SNPs, respectively, and the latter showed 8 SNP combinations within the *FASN* gene in LD that associated with obesity.^[@R13],[@R14]^ We performed LD analysis for all 4 SNPs in this study and managed to identify the rs4246445 and rs2229425, as well as the rs2229425 and rs2228305 SNP combinations were in strong LD with D' of 98% and 99%, respectively. However, the r^2^ values for both SNP combinations in LD were extremely low and therefore their effects seem to be independent of each other. One possible explanation is that the variant allele frequency for both rs2229425 and rs2228305 SNPs is exceptionally low in the population.

Our study also identified 3 haplotypes (TCGT, TCGC and CCAT) which were more common in overweight+obese subjects. Haplotypes CCGT and CCGC were more frequent in subjects with normal BMI. None of these haplotypes were evidently linked with obesity. Malaysia is a multi-ethnic country with a majority of Malays, Chinese and Indians, and some minor ethnic groups (i.e. KadazanDusun, Bajau, Orang Asli, etc). A recent review of obesity prevalence in Malaysia suggested that Malays and Indians are more obese than Chinese, and Orang Asli are the least obese ethnic group in Malaysia.^[@R24]^ Therefore it is worth to fully sequence the *FASN* gene of different ethnic groups in the Malaysian population to determine haplotype that may markedly contribute to obesity endemic in the country.

Conclusion {#s5}
==========

In conclusion, this study showed significantly higher hemoglobin and WBC levels in the obese individuals compared to the normal individuals. Lack of association was observed for all 4 SNPs (rs4246445, rs2229425, rs2228305 and rs2229422) within the *FASN* gene with the risk of overweight and obesity in the population, including in the different parameters assessed (i.e. gender, smoking status, alcohol consumption and fast-food intake). The rs4246445 and rs2229425, as well as the rs2229425 and rs2228305 SNP combinations, were in strong LD but the r^[@R2]^ values for both combinations were notably low, due to a low frequency of a variant allele in the rs2229425 and rs2228305 SNPs. Five common haplotypes were discovered in this study but none of them was evidently associated with the prevalence of overweight and obesity. We recommend to fully sequence the *FASN* gene of different ethnic groups in the Malaysian population to identify superior candidate of SNP combinations in LD and haplotypes that might be perceptibly linked with the risk of overweight and obesity.
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Research Highlights {#s9}
===================

What is current knowledge? {#research1}
--------------------------

1.  √ Obesity is commonly associated with several life-threatening diseases.

2.  √ Nearly half of the Malaysian adults are reported to be overweight and about 17.7% of them are obese.

3.  √ *FASN* gene is located at chromosome 17q25 that has the strongest evidence for linkage with the percentage of body fat.

4.  √ *FASN* rs4246445, rs2229425, rs2228305 and rs2229422 SNPs have been significantly associated with obesity risk in Germans, but yet to be investigated in the Malaysian population.

What is new here? {#research2}
-----------------

1.  √ Lack of evidences to associate the *FASN* rs4246445, rs2229425, rs2228305 and rs2229422 SNPs with the risk of overweight and obesity in the Malaysian population.

2.  √ All 4 SNPs are independent of each other.

3.  √ All identified haplotypes were not significantly linked with overweight and obesity in the population.
